Editas Medicine Cash from Financing (TTM) Trends

Editas Medicine Inc (EDIT)

5.67 +0.05 (+0.89%) USD | NASDAQ | May 03, 16:00

5.67 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	118.04M
September 30, 2023	118.14M
June 30, 2023	118.22M
March 31, 2023	1.066M
December 31, 2022	1.284M
September 30, 2022	1.722M
June 30, 2022	4.138M
March 31, 2022	20.85M
December 31, 2021	282.11M
September 30, 2021	290.15M
June 30, 2021	288.48M
March 31, 2021	482.55M
December 31, 2020	224.12M
September 30, 2020	299.59M
June 30, 2020	342.12M
March 31, 2020	133.34M
December 31, 2019	131.82M

Date	Value
September 30, 2019	77.61M
June 30, 2019	35.49M
March 31, 2019	35.79M
December 31, 2018	86.94M
September 30, 2018	115.07M
June 30, 2018	113.10M
March 31, 2018	110.12M
December 31, 2017	154.53M
September 30, 2017	95.52M
June 30, 2017	96.22M
March 31, 2017	96.04M
December 31, 2016	97.16M
September 30, 2016	93.95M
June 30, 2016	214.36M
March 31, 2016	236.82M
December 31, 2015	139.39M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.066M

Minimum

Mar 2023

482.55M

Maximum

Mar 2021

156.36M

Average

118.22M

Median

Jun 2023

Cash from Financing (TTM) Benchmarks